MétaCan
Menu
Back to cohort
Record W3131496390 · doi:10.1002/hep4.1664

Joint Efforts to Ensure Evidence‐Based Decisions by Clinicians in Drug Adjustment for Chronic Liver Disease Populations

2021· letter· en· W3131496390 on OpenAlexafffundabout
Victor H. Ferreira, Christian Vincelette, Alexandre Mathieu

Bibliographic record

VenueHepatology Communications · 2021
Typeletter
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsUniversité de SherbrookeCentre Hospitalier de l’Université de Montréal
FundersCanadian Institutes of Health Research
KeywordsMedicineContext (archaeology)DrugMultidisciplinary approachIntensive care medicineChronic liver diseaseMedical prescriptionCirrhosisDiseaseLiver diseasePharmacologyPathologyInternal medicinePolitical science

Abstract

fetched live from OpenAlex

TO THE EDITOR: We read with interest the article written by Hayward and Weersink entitled “Improving Medication-Related Outcomes in Chronic Liver Disease.”(1) We believe the authors meticulously highlighted and described the intricate factors influencing medication management–related outcomes in patients suffering from chronic liver disease (CLD). However, we emphasize the importance of acknowledging what we consider a crucial and unmet need in this field: data regarding the pharmacokinetic and pharmacodynamic alterations of drugs at varying degrees of CLD. In the context of cirrhosis, it has been reported that prescription drugs are often used precariously and prescribed by nonspecialist clinicians.(2) Unfortunately, these clinicians are faced with very few resources and data to help support evidence-based decision making. Some authors have attempted to bridge this gap by detailing altered pharmacokinetic and pharmacodynamic changes expected in patients with CLD and how drug adjustments might be attempted based on a specific pharmacokinetic profile.(3) These methods are useful but tedious and complex. On the other hand, drug monographs and tertiary references might offer recommendations on drug adjustment according to the severity of CLD. Yet, these recommendations are usually vague and merely state the obvious: “use [insert drug] carefully, owing to a lack of data.” Considering these observations, we would like to reveal the enterprise of clinicians who exhaustively summarized the literature regarding drug use in CLD. First, a multidisciplinary group based in the Netherlands developed an online resource(4) that covers various drugs and therapeutic drug classes. A Canadian multidisciplinary group created another(5) that offers drug-adjustment recommendations for various medications, with a thorough analysis of available data and references. These efforts offer readily available tools to support evidence-based decisions. By acknowledging the glaring need to promote evidence-based decisions in drug dosing with CLD populations and by gaining insight into these initiatives, we believe it may open the dialog for concerted efforts by international panels of experts. Hence, these efforts may ensure that clinicians, who are most often nonspecialists in CLD, can easily access information regarding drug adjustment in liver cirrhosis. Initiatives such as the ones we presented are a steppingstone in improving the care and safety of CLD patients. We invite researchers to develop or promote similar initiatives and to put them to the test with implementation research methods.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.274
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.230
GPT teacher head0.392
Teacher spread0.162 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes3
Has abstractyes

Explore more

Same venueHepatology CommunicationsSame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207